Money Matters TV

Money Matters TV 24-42 Shah


Listen Later

Kimon Hatza, Esq. of GrowthCounsel interviews Nikej N. Shah, M.D., CEO of Nirsum Laboratories about issues in Long-term opioid therapy: Unmet needs, Risks and Solutions with a new drug in Phase I testing with the FDA. Present drugs in use today are Bupremorphine, Methadone and Maltrexone.

The post Money Matters TV 24-42 Shah appeared first on Money Matters TV.

...more
View all episodesView all episodes
Download on the App Store

Money Matters TVBy Money Matters TV

  • 5
  • 5
  • 5
  • 5
  • 5

5

1 ratings